All In Biotech

BLA 017881 · Draximage

Technetium Tc 99m Albumin Aggregated Kit

Technetium Tc-99m Albumin Aggregated Kit · Injection

Last checked: Nov 20, 2026Latest source record: Dec 1, 2023 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1987

Dec 30, 1987

Approved uses

1

Original approval plus efficacy supplements

Registered trials

0

0 Phase 3, 0 recruiting

FAERS reports

30

5 serious, 1 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Feb 13, 2024.

DRAXIMAGE MAA, after radiolabeling with sodium pertechnetate Tc 99m, is indicated for: Lung scintigraphy as an adjunct in the evaluation of pulmonary perfusion in adults and pediatric patients. Peritoneovenous shunt scintigraphy as an aid in the evaluation of its patency in adult patients. DRAXIMAGE MAA, after radiolabeling with sodium pertechnetate Tc 99m, is a radioactive diagnostic agent indicated for: Lung scintigraphy as an adjunct in the evaluation of pulmonary perfusion in adults and pediatric patients. (1) Peritoneovenous shunt scintigraphy as an aid in the evaluation of its patency in adults. (1)

Mechanism: Following intravenous injection, more than 80% of the technetium Tc 99m albumin aggregated particles is trapped in the pulmonary alveolar capillary bed within 5 minutes. Following intraperitoneal injection, technetium Tc 99m albumin aggregated mixes with the peritoneal fluid. Clearance from the peritoneal cavity varies from insignificant, which may occur with complete shunt blockage, to very rapid clearance with subsequent transfer into the systemic circulation when the shunt is patent.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Dec 30, 1987 Original approval · Type 5 - New Formulation or New Manufacturer
1 products under this application
  • TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT · TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT N/A · INJECTABLE, INJECTION · Prescription

Clinical trials

Interventional ClinicalTrials.gov studies with "Technetium Tc-99m Albumin Aggregated Kit" as an intervention, any sponsor and status, largest first.

All 0 trials

No registered drug trials name this ingredient.

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • drug ineffective17
  • off label use3
  • product preparation issue3
  • pruritus3
  • radioisotope uptake increased3
  • accidental underdose2
  • dyspnoea2
  • product distribution issue2
  • product preparation error2
  • rash2
  • urticaria2
  • anaphylactic reaction1

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20141
20161
20171
20182
20192
20203
20214
20225
20233
20244
20254

Recalls

1 FDA enforcement reports for this application.

  • Jun 16, 2022 · Class II · Terminated

    Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 0 on PubMed

No PubMed clinical studies matched.

Sponsor: Draximage

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.